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Abstract 
Introduction About 500 000 blood units are collected from blood donors and 
used for the preparation of blood components for blood transfu-
sion in Sweden every year. The shelf life of a red blood cell 
(RBC) unit in SAGM solution is 42 days within a controlled 
temperature environment of 2-6˚C. There is limited knowledge 
about how time and especially temperature affect blood units. 
However, even today´s blood units all over the world are trans-
ported to different health care sites without a guaranteed quality 
control of the required cold-chain. 
 
Purpose The purpose of this thesis is to explore the actual temperature 
variation during internal storage and internal transports of blood 
units during its actual shelf life in its real environment. 
 
Method At the Blood Center at Ryhov the QTA Tracer System® was 
used log the temperature and time. Tracers were attached to 
blood bags that then were stored at the internal refrigerators or 
transported between Jönköping and Värnamo. 
The log-files were then analyzed with excel spreadsheet to iden-
tify individual blood bags, i.e. tracers, that were out of tempera-
ture range. 
 
Conclusions The test showed that there were actual deviations from the 
standards in the physical environments surrounding the blood 
bags even though the procedures were followed. To all the blood 
bags that reached below 0°C a control of their level of hemolysis 
were performed. The fact that all of them had well below the 
stipulated 0.8% of hemolysis could raise the question of the ‘ze-
ro-tolerance’ to go below 0°C due to the risk of hemolysis. 
The blood center made some minor changes to some of proce-
dures to reduce the deviations. They also continuously monitor 
their blood bags to incremental develop their routines. 
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1 Introduction 
1.1 Background 
Red blood cells (RBC) are an important ingredient in the modern emergency, trans-
plantation, hematology and health care system. RBC in vivo is known to have a 
lifespan of approximately 120 days. RBCs for medical use are normally derived from 
whole blood donations and stored in a cold environment in an additive solution for 
approximately 42 days [1, 2]. 
Sweden are today self-sufficient of blood cells but the availability of RBC are how-
ever scarce. Almost 500 000 whole blood units are collected from blood donors and 
used for the preparation of blood components for blood transfusion and production of 
blood components in Sweden every year. This amount is still sufficient enough but 
there is a trend that the pool of donors is diminishing both nationally and internation-
ally. This is due to the facts that lesser donors volunteer and through better planning, 
lesser elective surgeries and medical innovations that limit the bleeding during sur-
gery [3-5].  
The shelf life of a red blood cell RBC unit in a SAGM solution is 42 days within a 
controlled temperature environment of 2-6˚C. The handling of blood bags, pro-
cessing, storage and transport is regulated by different international, national and lo-
cal standards [6-8].  
There is limited knowledge about how time and especially temperature affect blood 
units. Reviews and articles publicized back since the fifties are not conclusive on the 
sensitiveness of blood bags [9]. According to Thomas et al. ‘Red cells may be dam-
aged to prolonged exposure to warm temperature, but repeated short-term exposure 
to +22C or -2C does not appear to affect the in vitro quality of RBC’[10]. This is in 
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line with the finding of Gulliksson et al. that argues ‘that quality of RBCs after tran-
sient warming will be maintained at acceptable levels’[11]. They though argue that  
‘increased haemolysis was observed …during the second part of the storage period .. 
suggesting that RBCs are more vulnerable to warming by the end of storage’[11]. 
Perry et al on the other hand argues that the timeframe for exposure should be de-
creased, partly due to the fact that there are a vast range of erythrocyte products, in 
different sizes available, which affects the warming process [12]. Another issue that 
have been addressed is in what way older blood affect the receiving patient in an 
transfusion situation and there are signs that at massive transfusions of older blood 
could in fact constitute a risk factor [4]. 
1.2 Problem Discussion 
However, even though the demands and regulations are quite clear about the ambi-
tion and demands on storage and transportation of erythrocytes there are today uncer-
tainties about the actual temperature that affects the blood bags during its shelf life. 
And even today blood units all over the world are transported to different health care 
sites without a guaranteed quality control of the required cold-chain. Professionals 
within the field are operating without full knowledge, sort of in a ‘dark-room’ [13]. 
Estimation of temperature deviation in storage and transport is largely based on a 
‘precautionary principle’ due to the fact that studies so far have been difficult to plan 
which results in the lack of scientific evidence. Probably this leads to the discarding 
of blood components unnecessarily and the use of blood components which should 
not be used, due to an insufficient knowledge of the actual state [13]. 
‘We need to distinguish between serious and minor temperature deviations. We need 
to primarily identify the real situation in our businesses’ [13]. 
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With better knowledge about the actual situation that affects the blood bags will the 
possibilities to develop better processes, minimize risks and optimize the handling of 
blood bag probably increase. 
1.3 Quality of RBC Due to Time and Temperature 
The understanding that blood is a sensitive commodity is widely accepted in the field 
of transfusion. Research as far back as to the fifties address the issue of the aging of 
blood, how time and temperature affects the blood both in vitro and in vivo and what 
consequences this bring to the outcome for the patient. And this field of interest 
seems to be of increased value and interest [4, 9, 14]. 
Even though there are a vast knowledge about some of the effects, presented below, 
that time and temperature have on erythrocytes there are today not an overall consen-
sus for how sensitive this makes the blood. There are however an acceptance that 
blood is a very complex tissue, that will be affected in different ways, and that the fi-
nal outcome in vivo depends on multiple factors and that extensive research need to 
be done [4]. 
1.3.1 Storage Lesions 
There is evidence that the erythrocytes will be affected in vitro during storage, i.e. 
storage lesions. The most influential storage lesions consists of; among others; de-
creased pH, increase of potassium and lactate, reduction of ATP and 2,3-DPG which 
leads to an increased rigidity and deformability and eventually haemolysis. The ef-
fects storage lesions have in vitro could be divided into; decreased oxygenation ca-
pacity, release of damaging components and hindered circulation capacity. There are 
also evidence that the effects of storage lesions will increase over time and when 
RBC are stored in too high or too low temperatures [1, 4, 9, 10, 14, 15]. 
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1.3.1.1 Decreased pH 
A decreased pH within the RBC will affect cell function partly by the change in con-
ditions of the cell proteins that will be displaced from its optimum in function at pH 
7.4. The lower pH of the cell will also consequently increase the affinity of oxygen 
inside the blood cell which results in a decrease in release of oxygen to the surround-
ing tissues. 
1.3.1.2 Reduced Release of Nitric Oxide, NO by Erythrocytes 
In the blood stream Nitric Oxide, NO, released by the erythrocytes affects the local 
vasodilation of the vessels. With lower oxygen pressure the release of NO rises 
which in turn leads to increased local vasodilation and also the availability of eryth-
rocytes to pass by and release oxygen. Within the stored RBC detected loss of S-
nitrosothiol-haemoglobin (SNO-Hb) after a few days has been shown to diminish the 
release of NO and also the vasodilative action [1]. 
1.3.1.3 Decrease of Potassium and Increase of Lactate Within the RBC 
Under normal circumstances the level of potassium within the cell is in balance be-
tween a passive leakage over the cell membrane and the Sodium-Potassium Pump, 
(Na+/K+ pump). During storage this pump will become almost inactive under +4 de-
grees temperature. This leads to a vast outflow of K+ from the cell to the cell medi-
um which could lead to server consequences as heart failure, arrhythmia and paraly-
sis, for the recipient, especially infants and newborns. The inactive pump mechanism 
also leads to a decrease in the exit transport of lactate from the RBC which in turn 
lowers the pH [1, 4, 16, 17]. 
1.3.1.4 Reduction of 2, 3-DPG and ATP 
Oxygen binds to hemoglobin and it subsequently creates a change in conformation to 
the hemoglobin to which it binds in a way that the hemoglobin affinity for extra oxy-
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gen increases. 2, 3-Diphosphoglycerate, 2, 3-DPG within the erythrocyte decease the 
adherence of oxygen to the hemoglobin’s of the erythrocyte and consequently the re-
lease of oxygen. During storage the levels of 2, 3-DPG, will rapidly decrease, proba-
bly due to an active phosphatase. The consequence of low levels of 2, 3-DPG is that 
the oxygen binds tighter to the hemoglobin. This result in that the transport of oxy-
gen into tissue will be complicated as the release of oxygen from the hemoglobin is 
getting more difficult [1, 2, 4].  
Also the levels of Adenosine triphosphate, ATP, will diminish during storage. The 
role of ATP are among other as a carrier of energy and facilitates the flexibility of 
the cell membrane, increases the viability of the cell and possess vasodilating proper-
ties [4]. 
1.3.1.5 Increased Rigidity and Deformability 
The decreased flexibility in the membrane leads 
to an increased rigidity of the erythrocyte. The 
result hereof will be a notable change of shape 
which leads to increased deformability and re-
duced interactions with the endothelial [4]. 
These morphological changes will be reversed 
after an early transfusion but will be irreversible 
at the end of a 42 days storage period [1]. See 
Figure 1. 
1.3.1.6 Haemolysis 
Eventually the RBC will hemolyse. This hemolyse is a consequence of an increase of 
parts of the RBCs that forms clusters and an increase of oxidation of the cell mem-
 Figure 1 The Change of Shape of The 
Erythrocytes During Storage [2]. 
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brane. Due to the hemolysis there will be an increase of free hemoglobin within the 
erythrocyte package. This free hemoglobin will bind and inactivate NO within the 
blood bag as well as in the endothelia and increase the vasoconstriction and further 
decrease the functions of RBC within the bloodstream [1, 4]. 
1.3.2 Bacterial Growth 
The reactions due to transfusion of contaminated RBCs tend to be severe since they 
usually are concomitant with infused endotoxin, the Gram-negative bacteria’s lipo-
polysaccharide, which causes the immense release of cytokines. The release of cyto-
kines results in major septical reactions as high fever, hypotension and nausea [18]. 
About one out of 30 000 blood bags are estimated to be contaminated with bacteria 
and in one out of 500 000 this results in a septical reaction and in one of 10 million 
this will result in a fatal reaction [18]. 
The vast majority of bacterial growths are though unlikely to occur below 10 degrees 
Celsius as they are unable to survive or perish at these temperatures even though 
some Gram-negative bacteria still could thrive under these conditions.  
If  the RBCs are stored in a to high temperature, above 10 degrees, there are re-
searches that find an increased risk that the bacterial growth will occur [18] but there 
are also studies that shows that that probability is overrated [19].  
1.3.3 Action to Improve the Storage Conditions 
The RBC are commonly stored in Europe within an additive solution containing So-
dium Chloride, Adenine, Glucose and Mannitol, (SAGM) to counteract the degrad-
ing and ageing of the erythrocytes. Each of the ingredients is added for a specific 
purpose; Sodium Chloride gives isotonicity, Adenine provides ATP, Glucose for the 
metabolism and Mannitol to halt the hemolysis. [14, 20].  
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To reduce the probability of bacteria entering the RBCs and to prevent the bacterial 
growth, routines have been implemented to enhance the disinfection of the donor arm 
and one have also developed a closed system production process with a sample di-
version pouch [19]. 
1.4 Regulation and Standards 
The process of blood components and the following blood transfusion are valued as a 
transplantation of living organs. The handling of blood bags are therefore strictly 
regulated by the authorities globally on an international level as well as on a national 
level. There are therefore similarities but as well differences between the different 
national legislations. Internationally there are initiatives and organizations as the 
World Health Organization (WHO) and The International Society of Blood Transfu-
sion (ISBT) and the International Federation of Red Cross and Red Crescent Socie-
ties (IFRC) described below, that strives to enhance collaboration and exchange of 
experiences as well as standardize the process and legislations internationally. 
1.4.1 European Union 
The co-operation concerning blood transfusion between different member states in 
Europe was initiated in the 1950s. A steering committee, European Committee on 
Blood Transfusion (CD-P-TS), within the European Directorate for Quality of Medi-
cines and HealtCare (EDQM) is responsible of steering and coordinating the activi-
ties concerning blood transfusion. There are also an expert committee, the Commit-
tee on Quality Assurance in Blood Transfusion Services (GTS) [6, 21]. They are 
guided by the following principles; promotion of voluntary, non-remunerated blood 
donation, mutual assistance, optimal use of blood and blood products, and protection 
of the donor and recipient. [6, 21]. 
 Introduction 
 
11 
The regulation valid to storage, transport and distribution conditions for blood and 
blood components are specified within the Commissions Directive 2004/33/EG, An-
nex IV [22].  
The steering committee will publish with regularity the ‘Guide to the preparation, use 
and quality assurance of blood components’. This guide considers and takes into ac-
count the Councils of Europe’s resolutions and recommendations within the field and 
are to be seen as the generally accepted European standard. All member states should 
‘… take all necessary measures and steps to ensure that the preparation, use and 
quality control of blood components are carried out in accordance with the guide-
lines…’ [6]. 
1.4.2 Sweden 
On a Swedish national level the blood bank establishment is since 1th of June, 2013, 
under the governance of the Health and Social Care Inspectorate, IVO. In order to 
conduct a blood establishment authorization from and an ongoing reporting to the 
IVO is required. [23].  
The legislations valid are ‘SOSFS 2009:28, Socialstyrelsens föreskrifter om 
blodverksamhet’ that complements the law (1995:831) on transplantation and the law 
(2006:496) on security of blood. 
These regulations have been interpreted by the Swedish Society for Transfusion 
Medicine, Svensk Förening för Transfusionsmedicin, to the Swedish Manual for 
Blood Centers, Handbok för Blodcentraler. This manual are recommended to be used 
(and are used) by the different Swedish municipalities and blood bank institutions 
that handles blood components [7]. 
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1.4.3 The International Society of Blood Transfusion (ISBT) 
The International Society of Blood Transfusion (ISBT) is an international society 
with members from over 100 countries that aims to ‘Facilitating knowledge about 
transfusion medicine to serve the interests of donors and patients'. They strive to fa-
cilitate international accepted standards for the transfusion medicine industry as well 
as educational materials and events with a global perspective [24]. 
ISBT was also the organization that initiated the intercontinental blood labeling sys-
tem ISBT 128. ‘ISBT 128 is the international information standard that defines data 
structures, barcode placement, product definitions and nomenclature databases for 
transfusion and transplantation.’ [25]. ISBT 128 is thereby the foundation for the la-
beling of blood bags in Sweden. 
1.4.4 The World Health Organization (WHO) 
Since 1975 the World Health Organization has been engaged in the process to en-
hance the safety of blood on a global level. Their Blood Transfusion Safety Pro-
gramme aims at ‘ensure provision of universal access to safe, quality and efficacious 
blood and blood products for transfusion, their safe and appropriate use, and also en-
suring blood donor and patient safety’[26]. They work among others through rec-
ommendations, policy advice, technical guidance and also funding support for their 
member states [26, 27].  
1.4.5 International Federation of Red Cross and Red Crescent Societies 
(IFRC) 
IFRC aim is together with the WHO ‘to develop a global framework to help achieve 
100 per cent voluntary blood donation in every country’[28]. Today this is accom-
plished in about 50 countries. The IFRC works with the different countries ministries 
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of health usually with the questions of education and recruitments of residents to 
voluntary blood donations [28]. 
1.4.6 Shelf Life 
The time period that the blood bags could be stored varies between regions. In the 
EU and northern America it is defined as the time after which approximately 75% of 
transfused erythrocytes will survive in the recipient's blood 24 h post transfusion. 
This time frame is dependent on the additive solution used, in Europe SAGM, and is 
most often 42 days. This limited time frame though has implications for the blood 
banks as shortage situations will sometimes occur, in particular at the regions of the 
major cities, when donors are celebrating holidays away from home. An extended 
duration due to better storage and new solutions would probably even out these sea-
sonal effects [1, 6, 22]. 
1.4.6.1 Storage Temperature 
Due to legislation as well as praxis has an ’30 minutes rule’ been established, that 
limits the time a RBC could be exposed to uncontrolled temperature above 10°C. Af-
ter his 30 minutes the RBC should not be returned to the blood bank for further dis-
tribution. This is set to prevent the RBC from being contaminated with bacterial 
growth. The background to this rule is the time it takes for the RBC to reaches a 
‘core temperature’ of 10°C, which is determined to affect the rate of bacterial growth 
as well as the quality of the RBC. This ‘30 minutes rule’ has recently been chal-
lenged and proposed to be extended to a ’60 minutes rule’ with the argument that it 
was created in the early seventies on whole blood and not on modern containers with 
additive solutions. More recent research also imply that the RBCs aren’t affected 
negatively with bacterial contamination if exposed to a warmer environment for up 
to 60 minutes. [10, 18, 29, 30]. There are however others that find the ’30 minutes 
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rule’ as to generous as there are a vast range of RBC products, among others smaller 
blood bags for pediatric use, that will reach a core temperature above the recom-
mended 10 degrees significantly faster than earlier estimated. A suggested solution to 
the problem is a policy there only RBC products ‘…that have reached a temperatures 
of greater than 10°C, using established methods to measure the surface temperature’ 
are deleted [12]. 
In accordance with this ’30 minutes rule’ the Swedish Manual for Blood Centers in 
chapter 6 stipulates that ‘Red blood cell units that are normally stored at 2-6°C may 
be kept until the expiration date if the temperature during 24 hours has exceeded 6°C 
but not 10°C.’ [7]. 
1.4.7 Transportation of Blood 
The ‘Commissions Directive 2004/33/EG, Appendix IV’ states that ‘Transport and 
distribution of blood and blood components at all stages of the transfusion chain 
must be under conditions that maintain the integrity of the product’ [22].  
The Councils ‘Guide to the preparation, use and quality assurance of blood compo-
nents’ construes this in its principles chapter 4, paragraph 15. Transportation of 
blood components that ‘It is recommended that some form of temperature indicator 
be used to monitor the in transit temperature’ and that ‘Validated transport systems 
should ensure that at the end of a maximum transit time of 24 hours the temperature 
should not have exceeded +10°C’ [6]. 
In Sweden the Swedish Manual for Blood Centrals in chapter 6 stipulates that ‘Blood 
units must be transported in such a way that the desired quality is maintained. At 
transport, the same temperature are required as for stationary storage’ [7]. 
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1.5 Wireless Sensor Technology 
Back in the nineties when the ISBT 128 standard was introduced it was foreseen that 
the bar codes should be complemented by digital devices to gather and carry infor-
mation. Even though the development, adoption and acceptance of the technology 
not have reached to its potential as soon as estimated, the potentials have not been 
ignored by the blood banks and transfusion industry [31-36].  
The use of wireless technology to the surveillance of the blood bags could provide 
professionals with an enhanced and easier access to critical medical information. The 
benefit for the patient as well as the professional should then be a safer, more effi-
cient and qualitative care. Some of the benefits that could be reached are the re-
placement of manual documentation by electronic documentation as well as automat-
ic identification, tracking and status monitoring of blood products from vein-to-vein 
in all of the stages in the production chain [31, 32, 36, 37]. Obviously even though 
the increased effectiveness is appealing when calculating on the return of the invest-
ment the overall safety for the patient and the reduced risk for human errors, i.e. 
mismatch of samples, mismatch at the bedside, could and should be the goal to 
achieve at for the transfusion organization [31, 38]. 
With the entrance and acceptance of modern wireless technology, minimal exact 
thermometers, mobile positioning system and energy efficient microcomputers con-
ditions are set to monitor, gather and distribute information about actual ambient set-
tings. This makes it possible to increase the quality and even the security for the pa-
tient [34].  
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1.6 Wireless Temperature Surveillance 
At Karolinska 
Sjukhuset, Hud-
dinge, a systematic 
monitoring of their 
internal transports 
are conducted in 
line with the Swedish 
Guidelines and as a part of their process of continuously quality improvement by 
measuring randomly selected blood transports through out the year. During a year 
one monitors at an average 150 transports of depot blood in cold environement. Dur-
ing 2012 a discrepancy of the temperatures, between the temperature at the departure 
and the temperature at the arrival, were identified. The 2012 surveillance showed that 
only 35% of the shipments were within the applicable quality limit below 10°C. 
There was also a noteworthy correlation of seasonal effects were the end temperature 
noticeable increased during the warmer month of May, June and July, see Figure 2 
[39]. 
To falsify the earlier 
findings a new se-
ries of measuments 
were performed 
during June 2013. 
87 RBCs from two 
Figure 2 Temperatures at Internal Transports at KS Huddinge, 2012 [1]. 
Figure 3 RBC Temperatures at Internal Transports at KS Huddinge,  
June 2013 [1]. 
 Introduction 
 
17 
blood centers through the course of three internal transports were monitored. All of 
these shipments were outside the recommended temperature range of 10°C, see Fig-
ure 3 [39]. 
1.7 Purpose 
The purpose of this thesis is to, through a quantitative gatehering of information, ex-
plore the actual temperature deviations from standards, during internal storage and 
internal transports of red blood cell units during its actual shelf life in its real envi-
ronment. 
 Materials and Methodology 
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2 Materials and Methodology 
2.1 Literature Study 
A literature study was conducted thru the website of University of Gothenburg by 
PubMed/MEDLINE. The author also used the search engine of Google to comple-
ment the information retrieved. The author focused on ‘the quality of blood during 
storage’, ‘storage lesions and bacterial growth during storage of blood’, ‘lean produc-
tion’ and ‘wireless real time monitoring’. 
2.2 Study design 
A nonexperimental, descripted research design were used as the objective of the 
testest not were to establish a cause-and-effect relation but to record the presence of 
certain variables[40]. A quantitative approach were used as quality is quantified and 
where the researcher emphasizes measuring the extent of occasions [41]. The author 
used the QTA Tracer System® to monitor the environment of bags of erythrocytes 
during internal transports and internal storages. The data collected were examined 
with Microsoft Excel to identify the real surrounding temperatures of the blood bags. 
2.3 QTA Tracer System® 
The system used to gather the information, log the temperature and time of blood 
bags in this study, was the QTA 
Tracer System® a sort of Labora-
tory Inventory Management Sys-
tem (LIMS) developed by the 
Swedish company Tridentify AB. 
The system consists of five parts; 
(Figure 4) the Tracer, the Access 
Figure 4. QTA Tracer System® - Overview 
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Point, the Check-In Node, the Web Portal and the Reader. The system is developed 
solely to monitor and enhance a good inventory management of blood bags. The sys-
tem is CE marked in Europe as a Medical Device Class II by the Notified Body of 
the Technical Research Institute of Sweden, SP. The system is also patented in Eu-
rope and the US [42].  
2.3.1 The Tracer 
The system revolves around the tracer that is mounted on the blood bag and monitors 
its surface temperature. In its easiest form the user interacts with QTA tracer by turn-
ing the tracer their hand and LED’s displays if the blood is ok (green light) or not ok 
(red light).  
The tracer is the collector and generator of in-
formation, a mobile data logging carrier, the 
size of Ø55mm x 9 mm (Figure 5). Built on 
the Texas Instrument, CC2540, a low-power, 
system-on-chip (SoC) for Bluetooth low ener-
gy applications. It consists among others of 
the Texas Instrument TMP112 digital temper-
ature sensor, the Panasonic battery, the con-
nectBlue OLP425 platform that process the 
algorithm, the MEMS LIS3DH low-power 3-
axis linear accelerometer and two LED-diodes that indicates status of the blood with 
a red or green light. The tracer measures temperatures in the range of -40 to +60°C. It 
receive and transfer information wireless with Bluetooth 4.0® to the Access Point, 
Figure 5. QTA Tracer Attached to Blood Bag 
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the Check In Node or the Reader [42]. See also Appendix 1. QTA Tracer Hardware 
Specifications. 
2.3.2 The Access Point 
The Access Point is a software installed and running on an ordinary PC that is 
equipped with a QTA Bluetooth USB dongle and a 2D hand scanner. This is the 
communication hub with multiple functions. At the Access Point the Tracer will be 
paired with, ‘married to’, a specific blood bag. This is also the software were the 
configuration of time and temperature ranges of the algorithm used to calculate the 
actual expiration date for the blood bags are specified. This information is then up-
loaded to the Tracer [42].  
After scanning a tracer the access point provides more extensive information from 
the tracer to analyze it. It facilitates also the information transfer from the tracer to 
the Web Portal for fully detailed information analyze. 
2.3.3The Web Portal 
The Web Portal contains all the information generated from of all the tracers within 
an organization. The information gathered from the tracers through the access point 
and the check-in nodes allows the user to sort out tracer specific information on a 
range of variables as storage and transport location, blood type, status of blood bags, 
change of status and more [42].  
The Web Portal is used to analyze the big data generated within the system. This is 
either done in the portal or after that the complete temperature vs. time logs for se-
lected blood bags has been exported. 
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2.3.4 The Check-In Node 
The Check-In Node is an app designed to be running on IPads (4th generation or lat-
er) or an IPhone 4S (or later) and is dependent on Bluetooth 4.0. It continuously reg-
isters tracers that are being moved within a radius of ten meters. The information reg-
istered from the tracer, actual blood validity and expiration date, are immediately 
transferred to the Web Portal over Wi-Fi or over the 3G net together with the GPS 
location of the Check-In Node [42].  
2.3.5 The Reader 
The Reader is an application designed for the IPhone 4S (or later) that allows one to 
scan a blood bag independently of location to extract information on the actual status 
of a specific blood bag on site. During the work with this thesis the possible infor-
mation to analyze were current expiration date of the blood bag and the  estimated 
time left when stored in various temperature ranges [42]. 
2.4 Selection of Respondents and Sites 
We introduced QTA Tracer System® to explore the actual temperature variation dur-
ing storage and deliverance of blood units during its actual shelf life in its real envi-
ronment. The pilot was implemented at the Transfusion Medicine at Ryhov County 
Hospital where over 13,000 blood donations are made every year. The Blood Center 
serves all of the three emergency hospital within the Jönköping’s County with a total 
of about 1 200 patient beds. The establishment is accredited by SWEDAC to ensure 
its high quality standard of analysis and organization [3, 43]. 
The fact that the Blood Center at Ryhov County Hospital nurtured an ambition to 
evaluate and develop its daily routines to ensure a safer production, storage and de-
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liverance of RBC to its patients as well as the location and size of the Blood Bank 
and its yearly production was considered as suitable for this initial study. 
2.5 Collecting and Processing of Data with QTA Tracer 
System® 
2.5.1 Manufacturing of Blood Bags at Jönköping Blood Center 
At Jönköping blood center the manufacturing process of blood bags consist of the 
following main processes from donation to transfusion, from vein-to-vein. Collec-
tion, Screening, Production, Storage and Distribution incl. Order Processing, Order 
Allocation and Shipping, Transfusion or Return Reconciliation, and Disposal (Figure 
6). 
 
 
Figure 6. Adapted Top-level Process Flow for Ryhov Blood Center [33]. 
 
2.5.1.1 Collection 
The County of Jönköping has of today six regular collection sites and one mobile 
unit. At the collection site the donor will be registered, fill in a digital questionnaire 
and pass a basic interview covering the donor’s health’s condition as well as lifestyle 
and travel activities. If find possible to donate, an amount of about 450 ml blood will 
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be collected from the donor, this amount is divided into two portions, one blood bag 
and a tree test tubes for clinical tests. At the donor site the blood will immediately be 
initially Hb tested and the result will be discussed with the donor. Both the bag and 
the test tubes will immediately be labeled with bar codes for correct identification in 
the process. The bags are here marked with the Tap number, Blood Type and Tap 
date. 
When the collection is done outside the County Hospital of Ryhov, both the test 
tubes and the whole blood bags will be inbound transported to the laboratory and the 
blood center at the County Hospital. 
2.5.1.2 Screening 
The test tubes are transported to the laboratory to be tested in accordance with the 
guidelines. The test consists of the donors Hb and blood type. Also tests for HBsAg, 
anti-HCV, anti-HIV 1+2 and antibodies to syphilis. The tests tubes are extracted 
from the closed systems test pouch before the actual tapping is done. 
2.5.1.3 Production 
The whole blood bag will be processed within the blood center. It will be fractioned 
thru centrifugation and divided in its portion of red blood cell concentrate, plasma 
and platelets. Finally here each product will be labeled in accordance with the ISBT 
128 bar codes standard and registered in ProSang, the administrative system used. 
The additional bar codes are; Component code and Expiration date. Together with 
Tap number, Blood type, and Tap date these make up to the five ISBT 128 bar codes 
used. 
2.5.1.4 Quarantine, Storage and Distribution incl. Order Processing 
After processing are the blood bags stored in a therefore designated quarantine re-
frigerator to be released after negative test results in the screening process. When re-
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leased the blood bag is transferred to one of three storage fridges or transported to the 
subsidiaries in Värnamo.  
When an order is placed, in written, a suitable blood bag is identified due to its typ-
ing, and actual date of production or expected date of expiration. The actual blood 
bag will be matched to the phenotype of the receiver’s blood to ensure that no miss 
match will occur due to difference in ABO type and RH type. One tests for the pres-
ence of ABO antigens and ABO antibodies (plasma grouping) as well as RhD anti-
gen and the presence of irregular red cell antibodies. 
2.5.1.5 Order Allocation and Shipping 
When this matching process is in order the selected blood bag will be complemented 
with a shipping order. The blood bag is then either placed in the fridge to be picked 
up later or stored in a cool bag with ice to be transported outside the care of the blood 
center to the actual ward. 
2.5.1.6 Transfusion 
At the ward the blood bag are stored in its cool bag or a local fridge. When it is suit-
able the blood bag will eventually be transfused to the recipient after that the patient 
ID is matched with the actual blood bag to prevent any bedside miss match. The 
blood bag will often be heated to some degree before transfusion not to cool down 
the patient too much.  
After the transfusion has been done the empty blood bag will be stored in the local 
fridge. This is done to ensure that the portion of the blood that are left within the bag 
should be available to further testing if the patient shows any reaction to the blood 
given. 
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2.5.1.7 Return Reconciliation 
If the blood bag of some reason not will be transfused it will be returned back to the 
blood center and handed over from one staff member to one of the designated staff at 
the center. In this process the one handing over the bag will declare that it has been 
stored correctly and this will noted in ProSang. In each case but especially if one 
cannot guarantee that the bag has been treated correctly the bag will be ocular in-
spected and the surface temperature will be noted. Questionable blood bags will fur-
ther be controlled due to their level of hemolysis. This control are made by storing 
the blood bags vertically in the refrigerator, to let the erythrocytes sediment, the color 
of the over most layer are then compared to a color comparator of Haemonetics® and 
in critical bags will then be checked through the HemoQue Low. Finally will the 
doctor in charge authorize a re-storage of the bag or discard it.  
2.5.1.8 Disposal 
There are primarily three reasons to discard a blood bag. At the blood center it could 
be outdated due to the fact that it has been positive during the initial screening pro-
cess, that it has been stored for more than 42 days and that on return at the blood cen-
ter the surface temperature of the blood bag are shown to be to warm. Finally it could 
be disposed in the care of the transfusion ward as the patient not has shown any reac-
tion to the blood that he or she has received.  
2.5.2 Blood Center Implementation 
In discussion with the manager of the blood center we agreed that the scoop of this 
thesis should focus on two areas of interest; Internal storage and Internal transports 
as described above. Finally the storage condition within the different refrigerators at 
the blood center in Jönköping and also the internal transports of blood bags between 
the blood center in Jönköping and the subsidiary in Värnamo were selected as test 
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environments. The trials were conducted thru two independent phases during the pe-
riod from November 2012 to September 2013. 
2.5.2.1 QTA Tracer System® Configuration 
During these tests the QTA Tracer System were configured based on the blood cen-
ters interpretation of the Swedish Guidelines definition in Chapter 4 and 6. The 
measuring interval was set to a three minutes pace, which means that every third mi-
nute a new record of the actual temperature are logged.  
2.5.2.2 Storage Condition 
During the test phase in total 80 traces were mounted on to 80 blood bags that were 
placed in one of four refrigerators (Dometic BR400). These bags were placed, five 
on each shelf, 20 pieces in each fridge, in total 80 tracers in accordance with the ar-
rangement below. The bags with the tracers were placed on every shelf, marked 1-4 
(Figure 7) and one in each corner and one in the middle of each shelf, marked 1-5 
(Figure 8). 
 
 
 
 
 
Figure 7. Shelf Identification 
in Refrigerators.  
Photo. V.Wadskog 
Figure 8. QTA Placement on Shelf. 
Photo. V.Wadskog. 
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2.5.2.3 Internal Transports 
At the blood center blood bags were combined with QTA Tracers. This moment 
were done in the Production process presented above. 
In May, August and September 2013 the internal transports of blood bags between 
the BLC in Jönköping and the subsidiary in Värnamo were monitored. These internal 
transports are a part of the Quarantine, Storage and Distribution incl. Order Pro-
cessing. Throughout the year there are ‘outbound’ transports from the blood center in 
Jönköping to Värnamo with ordered blood. The blood bags are packed together, in 
one to two layers, sealed off with air-filled bubble plastic on top and above this ice 
packs.  
The bag is sealed and does not open until 
it reaches its destination in Värnamo, ap-
proximately 75 km and 50 minutes later 
(Figure 9).  
In Värnamo, the blood bags the tracers 
are checked in thru the ‘Check-in Node’ 
and simultaneously placed in the distrib-
uted fridge. 
 
2.5.3 Processing of Data 
The data collected through the QTA Tracer System® were exported to Microsoft Ex-
cel for analysis. One tracer generates one log file that contains the information of 
Figure 9. Blood Bag Transportation Route, Jön-
köping - Värnamo. 
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UTC Date Time, Percent Remaining (Life), Temperature. Every third minute a new 
post is generated.  
All the files were examined and the data were sorted on a falling scale of the Tem-
perature. Posts that showed degrees below 2°C or over 10°C were identified and 
these posts were compared thru time to see if it was deviant from the stipulated 
standard and expected environment. 
2.5.4 Ethics 
The scope of this thesis, to gain better information of the actual environmental im-
pact on the blood bag will hopefully result in the development of processes that ena-
bles better availability of blood to patient, to gain for the patient.  
In accordance with Swedish Law should any research be approved and conducted 
only if it can be conducted with respect for human dignity and human rights and 
basic freedoms are heeded [44]. 
This thesis has been conducted in accordance with the standard operations at the 
blood center at Ryhov county hospital. The information carried with the QTA Tracer 
System® involves no information that is traceable to patients in the system. The 
scarce resource, the blood bags, has not been exposed to extraordinary conditions to 
gather information.  
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3 Results 
3.1 Empirical Data 
3.1.1 Storage Conditions 
During the one week period from the 30th of November to the 8th of December 2012 
in total 80 (n=80) tracers generated a 306 875 samples. During this week the meas-
ured temperatures at 75 positions (n=75), 93.75% were within the specified limit, 2-
10°C. 
All the specified positions in refrigerator No.1 and No.4 all were within the specified 
limit.  
At nine different occasions the measurements showed a to low temperature under the 
specified 2°C at five (n=5), 6.25%, of the 80 positions specified.(Figure 10) 
 
 
 
 
 
 
 
 
 
 
Figure 10. Temperature Deviations of Blood Bags at Storage. On nine different occasions a too 
low temperature are identified, under the specified 2°C, at five positions. 
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In fridge No.2, on shelf 2, position 4 (2-2-4) did the temperature at 17 occasions, dur-
ing 22 intervals, reached below 2°C. As every interval is three minutes, this means 
that the blood bags at 66 minutes were out of range at this position. At one of these 
occasions, during one interval, did it reached 0°C, but not below zero.  
In fridge No.3, used as quarantine fridge, the temperature reached during 129 inter-
vals below 2°C on four positions, position No.4 on shelf 2, 3 and 4 and also position 
No.5 on shelf 3. This is equivalent to 387 minutes out of temperature range. Fur-
thermore of these intervals the temperatures reaches 0°C at five different occasions 
on shelf 2, on position 4. On one of these occasions, also the position No.4 on shelf 3 
and 4 reaches 0°C. At no time this is a state for more than two subsequent intervals. 
3.1.2 Transport Conditions 
The 10th, 14th, 16th and 17th of May and during the period of August to September 
2013 were 88 (n=88) blood bags with tracers shipped to Värnamo. At two different 
shipments did the temperature reached below the lower temperature of 2°C for four, 
4,54%, of the marked blood bags. 
During the shipment on the 16th of May one blood bag, QTA Tracer No. 
S00121300556402, reached below 2°C during two hours, between 12:07 and 14:07. 
From 12:19 to 14:04 the log file shows 0°C. 
Again during the shipment on the 27th of August three blood bags reached below 
2°C, down to a -1°C. 
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− Blood bag with tracer No. S00121300975203 was below 2°C between 11:51 
and 14:00 during 43 intervals, at 0°C between 11:54 and 13:30 and reached   
-1°C between 12:03 to 13:33. 
− Blood bag with tracer No S00121300976003 was below 2°C between 11:54 
to 13:27, 0°C between 11:57 to 12:54 and reached -1°C between 12:03 to 
12:21 
− Blood bag with tracer No S00121300981403  was below 2°C between 11:53 
to 13:38, at 0°C between 11:56 to 13:02 and reached -1°C between 12:02 to 
12:26 
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4 Discussion 
4.1 Implications for Clinical Practice 
Even though the implications are evident concerning that there are actual deviations 
from the standards in the physical environments surrounding the blood bags this is a 
way to small study to draw any general conclusions on any level concerning clinical 
praxis of the handling process. 
Though did the knowledge raised through the evaluations encouraged the blood cen-
ter on a regional level to change one of their routines, the way the RBCs were packed 
in cool containers. 
- In the cool bags the earlier used air-filled bubble plastic that were used to dis-
tant the ice pack from the RBC are now replaced with a sheet of Styrofoam, 3 
cm thick. 
The increased knowledge of the storage conditions that the positions most exposed to 
coldness were the innermost ones, above all the position 4, to the left, in the quaran-
tine fridge also led to discussions about the way that RBC were placed in the refrig-
erators. 
- The inner most corner in the fridges will no longer be used to store RBCs. 
One way to prevent this could be to place plastic baskets in these areas to 
maintain a proper distant between the RBC and the cool air exhaust.  
At all the blood bags that reached below 0°C a control of their level of hemolysis 
were performed. This control were made by storing the blood bags vertically in the 
refrigerator, to let the erythrocytes sediment, the color of the over most layer were 
then compared to a color comparator of Haemonetics®. Only one of the blood bags 
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reached to level four, and was then tested through the HemoQue Low. All of them 
had well below the stipulated 0.8% degrees of hemolysis. This fact could raise the 
question of the ‘zero-tolerance’ to go below 0°C due to the risk of hemolysis. 
4.2 Implications for Future Research 
As this is a minor study of the actual environment that the blood bags are exposed to 
during parts of their shelf life, it would be interesting to further explore this area, 
with a larger sample group and also on the whole or other parts of the cold-chain as 
for instance the inbound transports. 
In accordance with earlier studies the work with thesis acknowledge the fact that 
there is a vast range of similar products, with other time and temperature specifica-
tions, and the interest to evaluate the actual environment for platelets or whole blood 
were raised [12]. 
This thesis focused on some of the internal process at the blood center. Another area 
of interest that has come to our attention is the actual routines for handling and stor-
age of blood bags in the actual clinical scene, as at the ICU, the surgical department 
and more. 
The apprehension that the RBC sometimes is exposed to high temperature is aknowl-
edged in earlier studies, and there are therefore also a different set of 
time/temperature range that the RBCs could exposed to. There are in the litteraure al-
so different opinions of the sensitivity of the RBCs to be exposed to to high tempera-
tures [9-11]. With this study we have noticed the fact that the risk for blood bags to 
be exposed to a too cold environment is not neglectable. The fact that despite this the 
RBC seems to maintain their quality, at least for a shorter period of time in a zero 
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degree environment, indicates that this would be of interest for future research to be 
performed.  
During the work with this thesis it has become evident to the author how sensitive 
the erythrocytes are, how complex the process of producing, storing and distributing 
blood bags are [1, 4, 7, 9, 10, 14, 15]. It's also the author's opinion that this complex 
reality has meant that there have been different interpretations of common theoretical 
standards across both national and international borders because of their experience 
[5, 7, 8, 22]. 
An experience made is that this individual degree of interpretation gives certain in-
dependence in relation to the Swedish guidelines and maybe even a conscious or un-
conscious reduced compliance. One reason to this may be that in Sweden, the medi-
cal responsible doctor becomes a practical escape route as doctors always can over-
ride the theoretical recommendations concerning time and temperature of the blood 
bags. Another reason may be that the actual temperature/time ratio probably is diffi-
cult to accurately estimate. A third reason may be that where you actually do follow-
ups, concerning degree of hemolysis, so turns out that rules and recommendations 
have been set at too high a level of security. One way to enhance the development 
towards more relevant time/temperature restrictions would probably be to evaluate 
the affect the time and temperature have on erythrocytes on a larger scale than has 
been done. The author reason based on this small thesis that this should include 
warmer as well as colder environment than expected. 
One concern of the author was that the experience of using the high level of comput-
er/electronics could have been perceived as complicated for the user or the environ-
ment. There were also signs of that in earlier literature concerning introduction of 
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RFID projects [38]. The author believes, however, that the level of IT maturity in 
Sweden regarding both mobile phones and computers, and the fact that much has 
been done in this maturation process the last five years, now made it natural to use 
this type of technique. One reflection is that almost all literature identified, related to 
wireless technology, regards RFID and specific readers as the possible solution to the 
health care organizations even though there now are other standard solutions possible 
as Bluetooth and handhelds as mobile phones and tablets [31-38]. 
In preparing this essay the author also identified incidents where individual blood 
bags were assumed to be correctly stored, but at closer analysis turned out to have 
been stored for a long time in room temperature. This highlights, the author reasons, 
the difficulty of actually being able to foresee this process manually since it involves 
so many people, often under time pressure, that in several stages transfer both blood 
bags and critical information about the bags. Furthermore, during the course of this 
work there has been an possible identification of differences between disposals, one 
within the blood establishment strictly related to the non-achievement of the quality 
of the blood bags but also one out in operations where loss of blood bags could be 
due to a general loss due to wrong orders, wrong deliveries or just carelessness. 
4.3 Methodological considerations 
One aspect of the thesis is that the author did not investigate if there were any specif-
ic circumstances that initiated the handling of the refrigerators that caused it to cool 
down, or if it was just ordinary handling process of the blood bags. If this aspect had 
been included perhaps some additional insights to the process could have been iden-
tified and perhaps also altered to maintain a better storage climate at the quarantine 
fridge. 
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Earlier studies have focused on the surface- and core temperature of the blood bags 
and evaluated the quality of the RBC on the behalf of regulations and the 30-minute-
rule [10, 12, 29] With this thesis the measurements of the surrounding air tempera-
ture ie. suface-temperature are done at a fairly detailed level of three minutes sample 
rate. This sample rate was chosen together with the blood center at Ryhov as to live 
up to the standards of monitoring even small deviations from the desired storage 
temperature. As it turned out with a too cold environment, this narrow tolerance 
made the tracer sensitive and indicates for ‘not valid’ at a fairly short period of devia-
tions.  
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5 Conclusions 
The measurements made in this thesis showed that there were actual deviations 
from the regulated standards in the physical environments surrounding the 
blood bags, even though the procedures were followed.  
To all the blood bags that reached below 0°C a control of their level of hemol-
ysis were performed. The fact that all of them had well below the stipulated 
0.8% degrees of hemolysis could raise the question of the ‘zero-tolerance’ to 
go below 0°C due to the risk of hemolysis. 
The blood center made some minor changes to the procedure of transport pack-
ing to reduce the deviations and they also continuously monitor their blood 
bags to incremental develop their routines. 
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Populärvetenskaplig sammanfattning 
Röda blodkroppar är en viktig del  i det moderna sjukvårdssystemet. Cirka 500 000 
enheter blod från blodgivare används för framställning av blodkomponenter för blod-
transfusion i Sverige varje år. Sverige är idag självförsörjande på blodceller, men 
tillgången på röda blodceller är knapp.  
Hållbarhetstiden för en blodpåse är 42 dagar om den förvaras i en kontrollerad miljö 
på 2-6˚C. Även om krav och regler är tydliga om vad som gäller för lagring och 
transport av röda blodkroppar finns det idag en osäkerhet kring hur den faktiska tem-
peraturen påverkar blodpåsar under dess livstid. Detta är av stor vikt då det över hela 
världen transporteras blod mellan olika vårdplatser utan att man idag kan garantera 
att detta görs i en tillräckligt kyld miljö. Det finns även en begränsad kunskap om hur 
tid och framför allt temperatur påverkar blodcellerna.  
 
Syftet med uppsatsen var att undersöka den verkliga temperaturvariation för blodpå-
sar under lagring och transporter under normala förutsättning i en normal miljö. Ar-
betet visade att det fanns faktiska avvikelser i temperatur för blodpåsarna, vid såväl 
lagring som transport, även om korrekta förfarandena efterföljdes. 
En ovänta upptäckt var att temperaturavvikelserna främst gällde att vissa av blodpå-
sarna blev för kalla, i vissa fall sjönk temperaturen till under 0°C. Enligt det svenska 
regelverket så då dessa blodpåsar kasseras. 
För alla de blodpåsar som utsattes för temperatur under 0°C genomfördes en kvali-
tetskontroll för att se hur stor del av de röda blodcellerna som hade förstörts. Dessa 
påsar uppvisade då med marginal en mindre grad förstörda röda blodceller än det av 
regelverket godkända 0,8%. Detta faktum påvisar vikten om kunskap om vad som 
händer med blodet då det idag är "noll-tolerans" för att gå under 0°C eftersom denna 
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regel annars kan leda till att användbart blod kasseras i onödan. Resultatet medförde 
också en förändrad transportrutin. 
Resultaten påvisar ett behov av bättre kunskap om vilka faktiska temperaturer som 
blodpåsar utsätts för men också ett stor behov av att förstå vad som händer med blo-
det vid olika verkliga temperaturer. Med bättre kunskap om verkliga förhållanden 
kan processer förbättras och utvecklas vilket gör att de donerade blodpåsarna an-
vänds på bästa sätt. Detta är viktigt ur såväl ekonomiskt som patientsäkerhetsper-
spektiv. 
 
Testerna genomfördes på blodcentralen vid länssjukhuset Ryhov där QTA Tracer 
System ® används för att logga verklig tid och temperatur. Tracers fästes på 168 
blodpåsar vid produktionstillfället och sedan lagrades dessa i kylskåp och/eller trans-
porteras mellan Jönköping och Värnamo. Loggfilerna analyserades därefter med ex-
cel-ark för att identifiera enskilda tracers, blodpåsar, som var utanför tillåtet tempera-
turområde. 
  
 Acknowledgement 
 
40 
Acknowledgement 
First I want to thank my supervisor Camilla Hesse for insightful and humble guid-
ance in the work process with this thesis. Prior to and during this work, I have con-
sulted and received input from a wide variety of people, you know who you are and 
and I want to thank you. 
An extra big thank you goes to the enthusiasts and all of the staff at the blood bank of 
Ryhov County Hospital without whom it would have been impossible for me to do 
this thesis. A special thanks addressed to Ann -Marie, Ingela, Therese, Viktor and 
Petra. 
For access to the specialized hardware, software, process ideas and feedback on the 
analysis of sensor information, I want to thank and highlight the committed staff at 
Tridentify AB. Leif, Mattias, Christian, Magdalena and Thomas. 
Finally, I thank my family, my parents and in-laws and particularly my patient, and 
supportive wife Erica and my children Elias and Iris for supporting me, helping me, 
and yield me the opportunity to live my dream by attending the medicine progamme 
and with this essay. I love you so unspeakable much. 
 
 References 
 
41 
References 
 
1. Lion, N., et al., Stored red blood cells: a changing universe waiting for its map(s). J 
Proteomics, 2010. 73(3): p. 374-85. 
2. Berg, J.M., J.L. Tymoczko, and L. Stryer, Biochemistry. 6. ed. 2007, New York, 
N.Y.: Freeman. xxxv, 1026, [86] s. 
3. Mohammad R. Abedi, M.-K.A., Per-Olof Forsberg, Rut Norda, Blodverksamheten 
i Sverige 2012: omfattning, kvalitet och säkerhet. 2013, Svensk Förening för 
Transfusionsmedicin: http://www.transfusion.se/?page_id=23. 
4. Tornqvist, F., et al., Transfusion av äldre blodprodukter kan utgöra en risk. 
Kunskapsläget om lagring och transfusionsrelaterade skador är oklart. Läkartidningen, 
2012. 109(14-15): p. 4. 
5. Callahan, R., As demand dwindles, US blood banks make big changes in staffing and blood-
collection system, in The Washington Post. 2013, Associated Press: 
http://www.washingtonpost.com/national/health-science/as-demand-
dwindles-us-blood-banks-make-big-changes-in-staffing-and-blood-collection-
systems/2013/10/10/f330291c-31d5-11e3-ad00-ec4c6b31cbed_story.html. 
6. Guide to the preparation, use and quality assurance of blood components - 16th Edition. 16 
ed. 2011: EDQM. 
7. Wikman, A., et al., Handbok för Blodcentraler. 2013, Svensk Förening för 
Transfusionsmedicin: http://www.transfusion.se/?page_id=21. 
8. Standards for Blood Banks and Transfusion Services, 28th edition 2012. 
9. Brunskill, S., et al., What is the maximum time that a unit of red blood cells can be safely 
left out of controlled temperature storage? Transfus Med Rev, 2012. 26(3): p. 209-223 
e3. 
10. Thomas, S., V. Hancock, and R. Cardigan, Repeated short-term warming of red blood 
cell concentrates has minimal effect on their quality. Vox Sang, 2012. 103(2): p. 113-21. 
11. Gulliksson, H. and A.S. Nordahl-Kallman, Effect of transient warming of red blood 
cells for up to 24 h: in vitro characteristics in CPD/saline-adenine-glucose-mannitol 
environment. Vox Sang, 2014. 106(1): p. 61-7. 
12. Perry, H.E., et al., Core temperature changes in resuspended red blood cells (RBCs) and 
pediatric RBCs removed from refrigerated storage. Transfusion, 2010. 50(1): p. 174-7. 
13. Gulliksson, H., Temperaturpåverkan på blodkomponenter. 2012. 
14. Kato, G.J., Understanding the erythrocyte storage lesion. Anesthesiology, 2012. 117(6): 
p. 1159-61. 
15. Dzieciatkowska, M., et al., Proteomic analysis of the supernatant of red blood cell units: the 
effects of storage and leucoreduction. Vox Sang, 2013. 105(3): p. 210-8. 
16. Åkerblom, O., Förvaring av erytrocyter för transfusion - Kvalitetsmål. 2012. 
17. Johannsson, G. Hyperkalemi. 2013  [cited 2013 2013-10-10]; Available from: 
http://www.internetmedicin.se/dyn_main.asp?page=899. 
18. Ramirez-Arcos, S., et al., Bacterial growth in red blood cell units exposed to uncontrolled 
temperatures: challenging the 30-minute rule. Vox Sang, 2013. 105(2): p. 100-7. 
19. McLaughlin N, S.I., Anderson D, Kahwash E, Bacterial growth in RBC units exposed 
to room temperature for greater than 30 minutes. Transfusion, 2010. 50(Supplement s2): 
p. 76a. 
20. D'Amici, G.M., et al., Red blood cell storage in SAGM and AS3: a comparison through 
the membrane two-dimensional electrophoresis proteome. Blood Transfus, 2012. 10 Suppl 
2: p. s46-54. 
 
 
 References 
 
42 
21. Background & Mission. 2013  2013-10-13]; Available from: 
http://www.edqm.eu/en/blood-transfusion-mission-65.html. 
22. COMMISSION DIRECTIVE 2004/33/EC - implementing Directive 2002/98/EC 
of the European Parliament and of the Council as regards certain technical requirements for 
blood and blood components, T.C.o.T.E. Communities, Editor. 2004: http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:091:0025:0039:EN:P
DF. p. 15. 
23. Rapportera blodverksamhet. 2003  [cited 2013 2013-10-10]; Available from: 
http://www.ivo.se/anmala-och-rapportera/rapportera-
blodverksamhet/Sidor/default.aspx. 
24. Home page - ISBT.  2013-10-21]; Available from: http://www.isbtweb.org. 
25. Home page - AABB.  2013-10-15]; Available from: 
http://www.aabb.org/Pages/Homepage.aspx. 
26. World Health Organization - Blood transfusion safety 2013  2013-11-12]; Available 
from: http://www.who.int/bloodsafety/en/. 
27. The Blood Cold Chain - Guide to the selection and procurement of equipment and accessories. 
2002  2013-11-12]; Available from: 
http://www.who.int/bloodsafety/testing_processing/components/en/BloodC
oldChain.pdf. 
28. IFRC - Blood services. 2013  2013-11-17]; Available from: 
http://www.ifrc.org/en/what-we-do/health/blood-services/. 
29. Thomas, S., V. Hancock, and R. Cardigan, The 30 minute rule for red blood cells: in 
vitro quality assessment after repeated exposure to 30 degrees C. Transfusion, 2013. 53(6): 
p. 1169-77. 
30. Dumani, D., D. Goldfinger, and A. Ziman, Is the 30-minute rule still applicable in the 
21st century? Transfusion, 2013. 53(6): p. 1150-2. 
31. Hohberger, C., et al., Applying radio-frequency identification (RFID) technology in 
transfusion medicine. Biologicals, 2012. 40(3): p. 209-13. 
32. Yao, W., C.H. Chu, and Z. Li, The adoption and implementation of RFID technologies in 
healthcare: a literature review. J Med Syst, 2012. 36(6): p. 3507-25. 
33. Davis, R., et al., Tracking blood products in blood centres using radio frequency 
identification: a comprehensive assessment. Vox Sang, 2009. 97(1): p. 50-60. 
34. Parlak, S., et al., Introducing RFID technology in dynamic and time-critical medical settings: 
requirements and challenges. J Biomed Inform, 2012. 45(5): p. 958-74. 
35. Kozma, N., et al., Impact of 13.56-MHz radiofrequency identification systems on the 
quality of stored red blood cells. Transfusion, 2011. 51(11): p. 2384-90. 
36. Ting, S.L., et al., Critical elements and lessons learnt from the implementation of an RFID-
enabled healthcare management system in a medical organization. J Med Syst, 2011. 35(4): 
p. 657-69. 
37. Dalton, J., et al., Using RFID Technologies to Reduce Blood Transfusion Errors. 2005, 
Intel Corp.: 
http://www.cisco.com/web/IT/local_offices/case_history/rfid_in_blood_tran
sfusions_final.pdf. p. 8. 
38. Sandler SG, L.A., Carty K, Dohnalek LJ., Bar Code and Radio-Frequency Technologies 
Can Increase Safety and Efficiency of Blood Transfusions. LabMedicine, 2006(37): p. 
436-439. 
39. Källman, A.-S. QTA Tracer System: Bakgrund, Pilotförsöket, Resultat. in 
Linköpingsdagarna 2013. 2013. Linköping. 
 References 
 
43 
40. Berg, K.E. and R.W. Latin, Essentials of research methods in health, physical education, 
exercise science, and recreation. 2. ed. 2004, Philadelphia: Lippincott Williams & 
Wilkins. xvi, 292 s. 
41. Patel, R. and B. Davidsson, Forskningsmetodikens grunder: Att planera,  genomföra och 
rapportera en undersökning. 2003: Studentlitteratur. 
42. QTA Tracer System, the Products. 2013  2013-11-15]; Available from: 
http://www.qtatracersystem.com/products. 
43. Home Page - Landstinget i Jönköpings län. 2013  2013-10-17]; Available from: 
http://www.lj.se/. 
44. CODEX - regler och riktlinjer för forskning. 2013  2013-12-15]; Available from: 
http://www.codex.uu.se/. 
 
  
 References 
 
44 
Appendix 1. QTA Tracer Hardware Specification 
The Tracer is based on a sensor module called cB-0950 made by ConnectBlue in Sweden. 
The cB-0950 product is a Bluetooth® low energy sensor module. The module is based on 
the 2.4-GHz Bluetooth® low energy System-on-Chip CC2540 from Texas Instrument (TI) and 
has an internal antenna. The module is equipped with: 
- An temperature sensor (TI TMP112) with max ±0.5°C +0/+65°C, ±1°C -40/+125°C 
accuracy.  
- An accelerometer (ST LIS3DH) which is primary used for detection of module 
movement but also for wakeup the module by clicking on the module. 
- A lithium coin cell BR2330A battery, 3V, 220mAh, Ø23x3mm. 
- Battery capacity supervision. 
- A red and a green LED. 
 
The module is estimated to have a lifetime of 3 years. The PCB (Printed Circuit Board) size is 
22.3x14.8mm and the BR2330A battery is soldered on the side of the PCB. The module has 
the operating temperature +85/-40 ºC and storage temperature +90/-40ºC but the battery 
specified up to +125 ºC.  
The module is Radio approved for usage in Europe (ETSI), USA (FCC ID: PVH0950) and Cana-
da (IC ID: 5325A-0950) and also Bluetooth Qualified. 
Electrical safety 
The electronics fulfill: 
EMC: EN 301 489-1 V1.8.1 (2008-04), EN 301 489-17 V1.3.2 (2008-04), EN 61000-6-2 (2005) 
Health and safety: EN 50371:2002, EN 60950-1:2006 and/or IEC 60950-1:2005 (2nd Edition) 
Medical Electric Equipment: IEC 60601-1-2 (2007) 
